VCT Resilience: Northern Venture Trust Navigates Tax Cut and Market Volatility

LONDON, UK – June 11, 2026 – In a year marked by economic turbulence and a seismic shift in UK investment policy, Northern Venture Trust PLC (NVT) has presented a case study in resilience. The venture capital trust’s annual report for the year ending March 31, 2026, revealed a complex picture of market-driven valuation pressures offset by strategic successes, robust investor support, and a steady hand on shareholder returns.

While net asset value (NAV) per share dipped to 57.8p from 61.5p the prior year, and the total return registered a modest loss of 0.6p per share, these figures belie a more nuanced story. The trust successfully raised an oversubscribed £30 million share offer and maintained its commitment to a 5.0% annualised dividend yield, signalling enduring confidence from its investor base even as the VCT sector faces its most significant headwind in nearly two decades.

Performance in a Turbulent Market

The financial year was a tale of two halves, culminating in a challenging final quarter. As noted by Chair Deborah Hudson, the portfolio's valuation was hit by late-year market volatility, driven by "investor concerns over the impact of AI on software company valuations, and macroeconomic uncertainty." This pressure was evident in the performance of the trust's largest holding, The Beauty Tech Group, which saw a temporary dip in its share price post-IPO, contributing to a valuation markdown at year-end.

Yet, beneath the headline NAV decline, the portfolio demonstrated its capacity for generating substantial returns. The year saw six exits, most notably the sale of software firm Idox plc. An investment originally made in 2007 for £0.2 million was realized for £2.2 million, delivering a staggering 9.4 times lifetime return. Furthermore, the successful IPO of The Beauty Tech Group allowed NVT to realize 30% of its holding for £2.5 million, securing a 5.8x return on its original investment.

This high-risk, high-reward nature of venture investing was also on display on the downside. The report disclosed a full write-down of Newcells Biotech, a pharmaceutical services provider, resulting in a £2.0 million reduction in value. Such outcomes are an inherent part of the VCT model, which aims to balance these losses with outsized gains from its successes. Several other portfolio companies showed strong growth, with pet food company Pure Pet Food increasing in value by £1.3 million and cybersecurity firm Risk Ledger growing by £0.9 million, underscoring the strength within the portfolio's core.

Bracing for the Tax Relief Shockwave

The most significant challenge facing NVT and the entire VCT ecosystem is the government's decision to slash income tax relief on new subscriptions from 30% to 20%, effective April 2026. The move has been widely condemned by industry experts, who point to a similar cut in 2006 that caused a two-thirds collapse in fundraising from which the sector took over a decade to recover.

In her statement, Chair Deborah Hudson expressed the board's disappointment, noting the change "runs counter to the Government’s stated commitment to supporting early-stage UK businesses." The concern is that while the government simultaneously increased the amount of capital VCTs can invest in a single company, these higher limits will be meaningless if VCTs cannot attract sufficient investor capital in the first place.

Anticipating the change, NVT acted decisively, extending its 2025/26 share offer to give investors a final opportunity to benefit from the more generous 30% relief. The move proved prescient, with the offer being fully subscribed. Industry analysts predict a "flight to quality" in the new, tougher fundraising environment, where established trusts with strong track records and consistent dividend policies like NVT are likely to fare better than smaller, less resilient funds. However, the overall pool of capital available for the UK's most innovative startups is now widely expected to shrink significantly.

A War Chest for Growth and Support

Despite the external pressures, Northern Venture Trust enters the new financial year from a position of strength. The successful £30 million fundraise, coupled with proceeds from disposals, has bolstered its cash position to a formidable £36.5 million. This liquidity provides a crucial war chest to not only pursue new opportunities but also to continue supporting its existing portfolio companies through their growth journey.

The trust remained an active investor throughout the year, deploying £6.9 million into four new companies and a further £8.7 million in follow-on funding to 18 existing portfolio companies. New additions include employee benefits platform Thanks Ben and Astral Systems, a developer of compact fusion reactors. The high proportion of follow-on funding reflects a maturing portfolio and a strategy of doubling down on proven winners, a critical function in a market where external funding has become more challenging for startups to secure.

Post year-end, the trust has already committed a further £2.0 million to two new ventures: Flok Health, an AI-enabled physiotherapy service, and Fifth Dimension AI, a decision-intelligence platform for the real estate sector. This continued deployment of capital into cutting-edge technology companies underscores the vital role NVT plays in translating British innovation into commercially viable enterprises.

The Evolving Landscape of Risk

Reflecting the rapid pace of technological change, the trust’s board has formally elevated "Artificial intelligence ('AI') and advanced technology risk" to a principal risk. This acknowledges the dual threat facing its portfolio: the risk that companies failing to adopt AI will face a competitive disadvantage, and the execution, regulatory, and valuation risks for those that do. This proactive risk management highlights the complexities of investing at the technological frontier.

The adviser, Mercia Fund Management, remains confident, citing the UK’s position as a leading hub for AI and deep tech as a supportive backdrop for future exits. With its diversified portfolio, substantial cash reserves, and a disciplined investment approach focused on credible paths to profitability, Northern Venture Trust appears well-equipped to navigate the uncertain economic and regulatory waters ahead, continuing its three-decade mission of funding the next generation of British business success.